Steve Jobs' Son Says GLP-1 Weight Loss Drugs Could Be Among Most Important Medicines Ever, With Potential Impact on Cancer

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Reed Jobs, founder of oncology-focused venture capital firm Yosemite and son of Apple Inc. Co-founder Steve Jobs, said GLP-1 drugs could have a significant impact on cancer and other diseases, describing them as some of the most important drugs to reach the market. In an interview with Fortune's Allie Garfinkle on "Term Sheet" published Wednesday, Jobs said the GLP-1 revolution has been one of the biggest scientific developments in biotechnology over the past three years. Don't Miss: A single bad hire can set a startup back years. Here are the 5 hires founders most often misjudge — and why Still Learning the Market?